English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/198705
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease

AuthorsJiménez-Panizo, Alba; Pérez, Paloma ; Rojas, A. M. ; Fuentes-Prior, Pablo; Estébanez-Perpiñá, Eva
KeywordsAndrogen insensitivity syndromes (AIS)
Androgen receptor
Glucocorticoid receptor
Hormone resistance
Ligand-binding domain
Multimerization
Prostate cancer
Protein structure
Issue DateAug-2019
PublisherBioScientífica
CitationEndocrine Related Cancer 26(8):R479-R497 (2019)
AbstractNuclear receptors are transcription factors that play critical roles in development, homeostasis and metabolism in all multicellular organisms. An important family of nuclear receptors comprises those members that respond to steroid hormones, and which is subdivided in turn into estrogen receptor (ER) isoforms α and β (NR3A1 and A2, respectively), and a second subfamily of so-called oxosteroid receptors. The latter includes the androgen receptor (AR/NR3C4), the glucocorticoid receptor (GR/NR3C1), the mineralocorticoid receptor (MR/NR3C2) and the progesterone receptor (PR/NR3C3). Here we review recent advances in our understanding of the structure-and-function relationship of steroid nuclear receptors and discuss their implications for the etiology of human diseases. We focus in particular on the role played by AR dysregulation in both prostate cancer (PCa) and androgen insensitivity syndromes (AIS), but also discuss conditions linked to mutations of the GR gene as well as those in a non-steroidal receptor, the thyroid hormone receptor (TR). Finally, we explore how these recent results might be exploited for the development of novel and selective therapeutic strategies.
Description18 páginas, 5 figuras, 1 tabla
Publisher version (URL)http://dx.doi.org/10.1530/ERC-19-0132
URIhttp://hdl.handle.net/10261/198705
DOI10.1530/ERC-19-0132
ISSN1351-0088
E-ISSN1479-6821
Appears in Collections:(CABD) Artículos
(IBV) Artículos
Files in This Item:
File Description SizeFormat 
2019 Endocr Relat Cancer 26-R479.pdf Embargoed until August 1, 20202,16 MBAdobe PDFThumbnail
View/Open    Request a copy
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.